standard elisas Search Results


94
Multi Sciences (Lianke) Biotech Co Ltd mouse elisa kits
Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum <t>ELISA</t> analysis of pro-tumorigenic cytokines IL-6 <t>and</t> <t>TGF-β1</t> in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.
Mouse Elisa Kits, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/Mouse+IL-24+ELISA+KIT+ELISA+Standard/pmc12256513-115-18-21
Average 94 stars, based on 1 article reviews
mouse elisa kits - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Innovative Research Inc active pai 1
Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum <t>ELISA</t> analysis of pro-tumorigenic cytokines IL-6 <t>and</t> <t>TGF-β1</t> in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.
Active Pai 1, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/Human+PAI-1+ELISA+Kit%2CStandard+for+the+Human+PAI-1+ELISA+Kit/med_rxiv__2023__10__18__23297216-61-18-12
Average 93 stars, based on 1 article reviews
active pai 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Tecan Systems infinite f50 microplate reader
Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum <t>ELISA</t> analysis of pro-tumorigenic cytokines IL-6 <t>and</t> <t>TGF-β1</t> in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.
Infinite F50 Microplate Reader, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/Infinite+F50%2C+Standard+configuration%2C+Absorbance+reader+for+ELISAs+in+96-well+plates%2C+wavelength+range+400-+750+nm/10__56808_slash_2673___060x__5424-60-12-16
Average 94 stars, based on 1 article reviews
infinite f50 microplate reader - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Multi Sciences (Lianke) Biotech Co Ltd rat il
Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum <t>ELISA</t> analysis of pro-tumorigenic cytokines IL-6 <t>and</t> <t>TGF-β1</t> in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.
Rat Il, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/Rat+IL-6+High+Sensitivity+Standard/pm39351093-65-8-53
Average 94 stars, based on 1 article reviews
rat il - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Innovative Research Inc human prorenin
Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum <t>ELISA</t> analysis of pro-tumorigenic cytokines IL-6 <t>and</t> <t>TGF-β1</t> in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.
Human Prorenin, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/Human+Prorenin+ELISA+Kit+for+Plasma%2FSerum%2CStandard+for+the+Human+Prorenin+ELISA+Kit/pm22930161-74-17-19
Average 90 stars, based on 1 article reviews
human prorenin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
ALPCO immunosolvent assay elisa kit
Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum <t>ELISA</t> analysis of pro-tumorigenic cytokines IL-6 <t>and</t> <t>TGF-β1</t> in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.
Immunosolvent Assay Elisa Kit, supplied by ALPCO, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/Zero+Standard+for+Mammalian+Insulin+ELISA+kits/pmc03840212-76-8-12
Average 96 stars, based on 1 article reviews
immunosolvent assay elisa kit - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Immunotec inc standard elisa kit
Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.
Standard Elisa Kit, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/standard+elisa+kit/pmc05198140-213-12-15
Average 90 stars, based on 1 article reviews
standard elisa kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EUROIMMUN standard elisa kit
Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.
Standard Elisa Kit, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/standard+elisa+kit/pmc05283559-143-11-14
Average 90 stars, based on 1 article reviews
standard elisa kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Standard Diagnostics Inc commercial elisa
Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.
Commercial Elisa, supplied by Standard Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/commercial+elisa/pmc06409741-110-9-11
Average 90 stars, based on 1 article reviews
commercial elisa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Standard Diagnostics Inc ns1 antigen panbiotm dengue early elisa
Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.
Ns1 Antigen Panbiotm Dengue Early Elisa, supplied by Standard Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/ns+1+antigen+panbio+dengue+early+elisa/pmc11733704-63-5-12
Average 90 stars, based on 1 article reviews
ns1 antigen panbiotm dengue early elisa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Alerchek Inc standard elisa
Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.
Standard Elisa, supplied by Alerchek Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/standard+elisa/10__1128_slash_cvi__00403___06-61-34-35
Average 90 stars, based on 1 article reviews
standard elisa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Endogen Inc standard elisa
Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.
Standard Elisa, supplied by Endogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/standard+elisas/standard+elisa/pm16152596-48-19-20
Average 90 stars, based on 1 article reviews
standard elisa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum ELISA analysis of pro-tumorigenic cytokines IL-6 and TGF-β1 in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: Frontiers in Pharmacology

Article Title: Characterization of lysine crotonylation-related lncRNAs for prognostic assessment and immune response in glioma

doi: 10.3389/fphar.2025.1573694

Figure Lengend Snippet: Experimental validation of POLR2J4 function in glioma drug resistance and tumor progression. (A) RT-qPCR confirming knockdown efficiency of POLR2J4 in U87 and U251 cells using three shRNAs. (B) Dose–response curves showing increased sensitivity to Cisplatin (CDDP) in POLR2J4 knockdown cells. (C) Relative cell viability in four groups after treatment with 8 μM CDDP for 48 h. (D,E) EdU staining and quantification of proliferative cells across four groups. (F–H) Transwell assays evaluating cell migration and invasion, with quantification of migrated and invaded cells. (I–K) In vivo tumor growth analysis in nude mice (sh-N.C. vs. sh-POLR2J4) using U87 cells, with representative images (I) , growth curves (J, n = 3), and final tumor weights (K) . (L) RT-qPCR analysis of chemoresistance-related genes (ABCB1, ABCC1, BCL2) in U87 cells, demonstrating significant downregulation in the POLR2J4 knockdown group. (M) Serum ELISA analysis of pro-tumorigenic cytokines IL-6 and TGF-β1 in tumor-bearing nude mice, indicating reduced circulating levels after POLR2J4 knockdown. (N,O) IHC staining and semi-quantitative analysis (IOD/mm 2 ) of TGF-β1 and PD-L1 in xenografts, indicating decreased expression in knockdown tumors. *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: The concentrations of interleukin-6 (IL-6) and transforming growth factor-β1 (TGF-β1) in the serum were measured using commercially available mouse ELISA kits (Multi Sciences Biotech, Hangzhou, China; catalog nos.

Techniques: Biomarker Discovery, Quantitative RT-PCR, Knockdown, Staining, Migration, In Vivo, Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Expressing

Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.

Journal: Disease Markers

Article Title: Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review

doi: 10.1155/2016/1804727

Figure Lengend Snippet: Comparison of the mean of IL-1 β concentration between different studies using the same analytical techniques.

Article Snippet: ELISA kit , Standard ELISA kit (Bender Med Systems, Vienna, Austria) , Standard ELISA kit (Immunotech, France) , Standard ELISA kit (RayBiotech) , Standard ELISA kit (Quantikine R & D System) , Standard ELISA kit (Biosource, Ontario, CA).

Techniques: Comparison, Concentration Assay, Enzyme-linked Immunosorbent Assay